Prescription Drug Information: Clobazam (Page 7 of 7)

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Clobazam Tablets

Rx Only

10 mg

NDC 68180-157-06

Container label of 30 Tablets

Image-04
(click image for full-size original)

Clobazam Tablets

Rx Only

10 mg

NDC 68180-157-06

Carton label of 30 Tablets

image-05
(click image for full-size original)

Clobazam Tablets

Rx Only

20 mg

NDC 68180-158-06

Container label of 30 Tablets

image-06
(click image for full-size original)

Clobazam Tablets

Rx Only

20 mg

NDC 68180-158-06

Carton label of 30 Tablets

image-07
(click image for full-size original)
CLOBAZAM clobazam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68180-157
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLOBAZAM (CLOBAZAM) CLOBAZAM 10 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SILICON DIOXIDE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STARCH, CORN
Product Characteristics
Color WHITE (off-white) Score 2 pieces
Shape OVAL Size 9mm
Flavor Imprint Code L;7
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68180-157-09 1 BOTTLE in 1 CARTON contains a BOTTLE
1 90 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-157-09)
2 NDC:68180-157-01 1 BOTTLE in 1 CARTON contains a BOTTLE
2 100 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-157-01)
3 NDC:68180-157-02 1 BOTTLE in 1 CARTON contains a BOTTLE
3 500 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-157-02)
4 NDC:68180-157-06 1 BOTTLE in 1 CARTON contains a BOTTLE
4 30 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-157-06)
5 NDC:68180-157-07 1 BOTTLE in 1 CARTON contains a BOTTLE
5 60 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-157-07)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA210545 05/08/2019
CLOBAZAM clobazam tablet
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:68180-158
Route of Administration ORAL DEA Schedule CIV
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
CLOBAZAM (CLOBAZAM) CLOBAZAM 20 mg
Inactive Ingredients
Ingredient Name Strength
CELLULOSE, MICROCRYSTALLINE
LACTOSE MONOHYDRATE
MAGNESIUM STEARATE
SILICON DIOXIDE
SODIUM STARCH GLYCOLATE TYPE A POTATO
STARCH, CORN
Product Characteristics
Color WHITE (off-white) Score 2 pieces
Shape OVAL Size 11mm
Flavor Imprint Code L;8
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:68180-158-09 1 BOTTLE in 1 CARTON contains a BOTTLE
1 90 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-158-09)
2 NDC:68180-158-01 1 BOTTLE in 1 CARTON contains a BOTTLE
2 100 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-158-01)
3 NDC:68180-158-02 1 BOTTLE in 1 CARTON contains a BOTTLE
3 500 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-158-02)
4 NDC:68180-158-06 1 BOTTLE in 1 CARTON contains a BOTTLE
4 30 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-158-06)
5 NDC:68180-158-07 1 BOTTLE in 1 CARTON contains a BOTTLE
5 60 TABLET in 1 BOTTLE This package is contained within the CARTON (68180-158-07)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA210545 05/08/2019
Labeler — Lupin Pharmaceuticals, Inc. (089153071)
Registrant — LUPIN LIMITED (675923163)
Establishment
Name Address ID/FEI Operations
LUPIN LIMITED 650759348 MANUFACTURE (68180-157), MANUFACTURE (68180-158), PACK (68180-157), PACK (68180-158)

Revised: 05/2021 Lupin Pharmaceuticals, Inc.

RxDrugLabels.com provides trustworthy package insert and label information about marketed prescription drugs as submitted by manufacturers to the U.S. Food and Drug Administration. Package information is not reviewed or updated separately by RxDrugLabels.com. Every individual prescription drug label and package insert entry contains a unique identifier which can be used to secure further details directly from the U.S. National Institutes of Health and/or the FDA.

Medication Sections

Medication Information by RSS

As a leading independent provider of trustworthy medication information, we source our database directly from the FDA's central repository of drug labels and package inserts under the Structured Product Labeling standard. RxDrugLabels.com provides the full prescription-only subset of the FDA's repository. Medication information provided here is not intended as a substitute for direct consultation with a qualified health professional.

Terms of Use | Copyright © 2021. All Rights Reserved.